Manion Douglas J. insider trades
Manion Douglas J. has filed 9 Form 4s with the SEC that we hold, for Aclaris Therapeutics, Inc. (ACRS) (Pres and CEO, Director) and ARNA (EVP Research & Development). Across all of them we count 2 purchases worth $99.8K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 6,500 shares of Aclaris Therapeutics, Inc. worth $50.3K, dated 2023-03-09. The first filing on our record is dated 2021-08-17 and the latest 2024-01-03.
Aclaris Therapeutics, Inc. (ACRS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-03-09 | P, purchase reported on Form 4 | 6,500 | $50.3K | 2023-03-09 |
| 2023-03-17 | P, purchase reported on Form 4 | 6,300 | $49.5K | 2023-03-17 |
ARNA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1875875) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms